ENOVIS CORP (ENOV) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:ENOV - US1940141062 - Common Stock
23.97 USD
-0.29 (-1.2%)
23.97 USD
0 (0%)
Overall ENOV gets a fundamental rating of 4 out of 10. We evaluated ENOV against 186 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of ENOV while its profitability can be described as average. ENOV is valued quite cheap, while showing a decent growth score. This is a good combination!
1. Profitability
1.1 Basic Checks
- ENOV had positive earnings in the past year.
- In the past year ENOV had a positive cash flow from operations.
- The reported net income has been mixed in the past 5 years: ENOV reported negative net income in multiple years.
- Of the past 5 years ENOV 4 years had a positive operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of -30.84%, ENOV is in line with its industry, outperforming 42.47% of the companies in the same industry.
- The Return On Equity of ENOV (-67.66%) is comparable to the rest of the industry.
- ENOV's Return On Invested Capital of 0.12% is fine compared to the rest of the industry. ENOV outperforms 65.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -30.84% | ||
| ROE | -67.66% | ||
| ROIC | 0.12% |
ROA(3y)-6.18%
ROA(5y)-3.42%
ROE(3y)-11.19%
ROE(5y)-6.16%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With a decent Operating Margin value of 0.25%, ENOV is doing good in the industry, outperforming 65.05% of the companies in the same industry.
- ENOV's Operating Margin has declined in the last couple of years.
- ENOV has a Gross Margin (57.19%) which is comparable to the rest of the industry.
- ENOV's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.25% | ||
| PM (TTM) | N/A | ||
| GM | 57.19% |
OM growth 3YN/A
OM growth 5Y-43.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.41%
GM growth 5Y6.07%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ENOV is destroying value.
- Compared to 1 year ago, ENOV has more shares outstanding
- Compared to 5 years ago, ENOV has more shares outstanding
- The debt/assets ratio for ENOV is higher compared to a year ago.
2.2 Solvency
- ENOV has an Altman-Z score of 0.74. This is a bad value and indicates that ENOV is not financially healthy and even has some risk of bankruptcy.
- ENOV has a Altman-Z score (0.74) which is comparable to the rest of the industry.
- ENOV has a debt to FCF ratio of 59.72. This is a negative value and a sign of low solvency as ENOV would need 59.72 years to pay back of all of its debts.
- ENOV has a Debt to FCF ratio of 59.72. This is in the better half of the industry: ENOV outperforms 67.20% of its industry peers.
- A Debt/Equity ratio of 0.66 indicates that ENOV is somewhat dependend on debt financing.
- The Debt to Equity ratio of ENOV (0.66) is worse than 65.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 59.72 | ||
| Altman-Z | 0.74 |
ROIC/WACC0.01
WACC9.65%
2.3 Liquidity
- ENOV has a Current Ratio of 2.22. This indicates that ENOV is financially healthy and has no problem in meeting its short term obligations.
- ENOV has a Current ratio of 2.22. This is comparable to the rest of the industry: ENOV outperforms 43.55% of its industry peers.
- A Quick Ratio of 1.16 indicates that ENOV should not have too much problems paying its short term obligations.
- ENOV's Quick ratio of 1.16 is on the low side compared to the rest of the industry. ENOV is outperformed by 69.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.22 | ||
| Quick Ratio | 1.16 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 26.14% over the past year.
- ENOV shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -16.18% yearly.
- ENOV shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.57%.
- Measured over the past years, ENOV shows a decrease in Revenue. The Revenue has been decreasing by -8.73% on average per year.
EPS 1Y (TTM)26.14%
EPS 3Y-23.78%
EPS 5Y-16.18%
EPS Q2Q%2.74%
Revenue 1Y (TTM)11.57%
Revenue growth 3Y13.9%
Revenue growth 5Y-8.73%
Sales Q2Q%8.65%
3.2 Future
- The Earnings Per Share is expected to grow by 23.19% on average over the next years. This is a very strong growth
- The Revenue is expected to grow by 8.87% on average over the next years. This is quite good.
EPS Next Y14.67%
EPS Next 2Y11.49%
EPS Next 3Y11.76%
EPS Next 5Y23.19%
Revenue Next Year7.37%
Revenue Next 2Y5.98%
Revenue Next 3Y6.01%
Revenue Next 5Y8.87%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 7.20, the valuation of ENOV can be described as very cheap.
- Compared to the rest of the industry, the Price/Earnings ratio of ENOV indicates a rather cheap valuation: ENOV is cheaper than 97.85% of the companies listed in the same industry.
- The average S&P500 Price/Earnings ratio is at 27.38. ENOV is valued rather cheaply when compared to this.
- With a Price/Forward Earnings ratio of 6.81, the valuation of ENOV can be described as very cheap.
- Based on the Price/Forward Earnings ratio, ENOV is valued cheaper than 98.39% of the companies in the same industry.
- ENOV's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.29.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.2 | ||
| Fwd PE | 6.81 |
4.2 Price Multiples
- 93.01% of the companies in the same industry are more expensive than ENOV, based on the Enterprise Value to EBITDA ratio.
- 73.12% of the companies in the same industry are more expensive than ENOV, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 60.22 | ||
| EV/EBITDA | 9.07 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.49
PEG (5Y)N/A
EPS Next 2Y11.49%
EPS Next 3Y11.76%
5. Dividend
5.1 Amount
- No dividends for ENOV!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
23.97
-0.29 (-1.2%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)02-24 2026-02-24/amc
Inst Owners117.36%
Inst Owner Change-0.46%
Ins Owners1.14%
Ins Owner Change0.81%
Market Cap1.37B
Revenue(TTM)2.23B
Net Income(TTM)-1.37B
Analysts83.53
Price Target46.36 (93.41%)
Short Float %14.97%
Short Ratio9.89
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.55%
Min EPS beat(2)7.76%
Max EPS beat(2)13.35%
EPS beat(4)4
Avg EPS beat(4)8.22%
Min EPS beat(4)4.97%
Max EPS beat(4)13.35%
EPS beat(8)8
Avg EPS beat(8)7.21%
EPS beat(12)12
Avg EPS beat(12)8.15%
EPS beat(16)16
Avg EPS beat(16)8.66%
Revenue beat(2)0
Avg Revenue beat(2)-0.15%
Min Revenue beat(2)-0.21%
Max Revenue beat(2)-0.09%
Revenue beat(4)0
Avg Revenue beat(4)-0.8%
Min Revenue beat(4)-1.97%
Max Revenue beat(4)-0.09%
Revenue beat(8)2
Avg Revenue beat(8)-0.81%
Revenue beat(12)4
Avg Revenue beat(12)-0.8%
Revenue beat(16)5
Avg Revenue beat(16)-4.71%
PT rev (1m)-5.52%
PT rev (3m)-16.34%
EPS NQ rev (1m)0.14%
EPS NQ rev (3m)-5.21%
EPS NY rev (1m)0.1%
EPS NY rev (3m)1.83%
Revenue NQ rev (1m)-0.11%
Revenue NQ rev (3m)-1.37%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)0.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.2 | ||
| Fwd PE | 6.81 | ||
| P/S | 0.61 | ||
| P/FCF | 60.22 | ||
| P/OCF | 6.31 | ||
| P/B | 0.68 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.07 |
EPS(TTM)3.33
EY13.89%
EPS(NY)3.52
Fwd EY14.67%
FCF(TTM)0.4
FCFY1.66%
OCF(TTM)3.8
OCFY15.84%
SpS39.05
BVpS35.33
TBVpS-8.37
PEG (NY)0.49
PEG (5Y)N/A
Graham Number51.45
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -30.84% | ||
| ROE | -67.66% | ||
| ROCE | 0.15% | ||
| ROIC | 0.12% | ||
| ROICexc | 0.12% | ||
| ROICexgc | 0.34% | ||
| OM | 0.25% | ||
| PM (TTM) | N/A | ||
| GM | 57.19% | ||
| FCFM | 1.02% |
ROA(3y)-6.18%
ROA(5y)-3.42%
ROE(3y)-11.19%
ROE(5y)-6.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-45.54%
ROICexc growth 3YN/A
ROICexc growth 5Y-43.8%
OM growth 3YN/A
OM growth 5Y-43.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.41%
GM growth 5Y6.07%
F-Score4
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 59.72 | ||
| Debt/EBITDA | 4.5 | ||
| Cap/Depr | 66.6% | ||
| Cap/Sales | 8.7% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 72.98% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.22 | ||
| Quick Ratio | 1.16 | ||
| Altman-Z | 0.74 |
F-Score4
WACC9.65%
ROIC/WACC0.01
Cap/Depr(3y)55.91%
Cap/Depr(5y)50.8%
Cap/Sales(3y)7.49%
Cap/Sales(5y)6.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.14%
EPS 3Y-23.78%
EPS 5Y-16.18%
EPS Q2Q%2.74%
EPS Next Y14.67%
EPS Next 2Y11.49%
EPS Next 3Y11.76%
EPS Next 5Y23.19%
Revenue 1Y (TTM)11.57%
Revenue growth 3Y13.9%
Revenue growth 5Y-8.73%
Sales Q2Q%8.65%
Revenue Next Year7.37%
Revenue Next 2Y5.98%
Revenue Next 3Y6.01%
Revenue Next 5Y8.87%
EBIT growth 1Y-35.24%
EBIT growth 3YN/A
EBIT growth 5Y-48.51%
EBIT Next Year76.68%
EBIT Next 3Y28.42%
EBIT Next 5Y28.11%
FCF growth 1Y122.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y609.06%
OCF growth 3Y-31.69%
OCF growth 5Y-2.82%
ENOVIS CORP / ENOV FAQ
What is the ChartMill fundamental rating of ENOVIS CORP (ENOV) stock?
ChartMill assigns a fundamental rating of 4 / 10 to ENOV.
What is the valuation status of ENOVIS CORP (ENOV) stock?
ChartMill assigns a valuation rating of 8 / 10 to ENOVIS CORP (ENOV). This can be considered as Undervalued.
Can you provide the profitability details for ENOVIS CORP?
ENOVIS CORP (ENOV) has a profitability rating of 4 / 10.
What is the earnings growth outlook for ENOVIS CORP?
The Earnings per Share (EPS) of ENOVIS CORP (ENOV) is expected to grow by 14.67% in the next year.